Perfil
Mr. Frédéric Dumais is a Director-Communications & Investor Relations at ChitogenX, Inc., a Director-Communications & Investor Relations at Valeo Pharma, Inc. and a Member at Québec Bar Assoication.
Mr. Dumais was previously employed as a Senior Director-Communications & IR by Liminal BioSciences, Inc., a Vice President-Investor Relations by Akela Pharma, Inc., a Head-Investor Relations by Janssen Pharmaceutica NV, and a Vice President-Investor Relations by LAB International, Inc.
Cargos activos de Frédéric Dumais
| Empresas | Cargo | Inicio |
|---|---|---|
| VALEO PHARMA INC. | Contacto de Relaciones con Inversores | 01/06/2019 |
| CHITOGENX INC. | Contacto de Relaciones con Inversores | 01/06/2019 |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Frédéric Dumais.
| Empresas | Cargo | Fin |
|---|---|---|
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Public Communications Contact | 13/07/2007 |
| LIMINAL BIOSCIENCES INC. | Contacto de Relaciones con Inversores | - |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Contacto de Relaciones con Inversores | - |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Public Communications Contact | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Liminal BioSciences, Inc.
Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Finance |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
ChitogenX, Inc.
ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
Valeo Pharma, Inc.
Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
- Bolsa de valores
- Insiders
- Frédéric Dumais
















